Plain-English translation of NCT05880914 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is looking for better blood tests and markers that can help doctors understand and treat bone problems that develop as a result of kidney disease. When kidneys fail, they can no longer control hormones that keep bones healthy, leading to weak bones and fractures. The researchers want to find new biomarkers—measurable signs in your blood—that can more accurately show what type of bone problem you have, so doctors can choose the right treatment for you.
Current blood tests and bone biopsies don't always give doctors the full picture of what's happening in bone, especially in the outer part of the bone where fractures most commonly occur. Over the past 25 years, broken bones have become more common in kidney disease patients even though doctors are trying to treat the problem—suggesting that better ways to diagnose and monitor bone health are urgently needed.
You likely qualify if…
You likely don't qualify if…
You would visit the study clinic 4 times over 6 months. At these visits, you'll answer some health questions, have blood drawn for research tests, undergo a bone density scan (similar to an X-ray), and have a small bone biopsy taken (a needle collects a tiny sample of bone tissue). The bone biopsy helps researchers see exactly what's happening in your bone, and it's a procedure your doctor may have already recommended as part of your regular care for kidney disease bone problems.
AI-generated summary from trial data · Jun 15, 2026 · Not medical advice
United States